Sienna Biopharmaceuticals, Inc.
Sienna Biopharmaceuticals, Inc. (SNNA) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 72 transactions totaling $19.5M, demonstrating a bullish sentiment with $16.1M in net insider flow. The most recent transaction on Oct 2, 2019 involved a transaction of 2,396 shares valued at $551.
SNNA Insider Activity Summary
Who Is Buying SNNA Stock?
No significant insider buying has been recorded for SNNA in the recent period.
Who Is Selling SNNA Stock?
No significant insider selling has been recorded for SNNA in the recent period.
Is Sienna Biopharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SNNA is bullish with an Insider Alignment Score of 91/100 and a net flow of $16.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
SNNA Frequently Asked Questions
Understanding SNNA Insider Activity
Insider trading at Sienna Biopharmaceuticals, Inc. (SNNA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading SNNA stock, having executed 72 transactions in the past 90 days. The most active insider is Kristina Burow (Executive), who has made 7 transactions totaling $5.4M.
Related Tools
Track Sienna Biopharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at SNNA file new Form 4 transactions